Wind-Cold Dispersing

Ma Huang

Ephedrae Herba (Ephedra sinica stem) — A Comprehensive Traditional Chinese Medicine Educational Guide

Last updated: July 20, 2026·Medically reviewed by TCMIO Editorial Team·~12 min read

Ma Huang (Ephedra sinica) — dried yellowish-green jointed stems. Source: Dongwei Bencao

Key Takeaways

  • Ma Huang is the dried stem of Ephedra sinica Stapf (Ephedraceae), traditionally used in TCM to release exterior Wind-Cold, open the Lung, stop wheezing, and promote urination.
  • It contains ephedrine, pseudoephedrine, norephedrine, and ephedroxane — sympathomimetic alkaloids with significant cardiovascular effects including increased heart rate and blood pressure.
  • Ma Huang carries significant cardiovascular risk. It is banned as a dietary supplement in the US and restricted or banned in many countries. It should ONLY be used under direct professional supervision.
  • Always consult a qualified healthcare provider. This herb is contraindicated in hypertension, heart disease, hyperthyroidism, and many other conditions.

Important Safety Notice

This page is for educational purposes only. It does not provide dosage recommendations, treatment plans, or individualized herbal advice. Ma Huang contains ephedrine, a potent sympathomimetic amine that can cause serious cardiovascular events including heart attack, stroke, and death. It is banned as a dietary supplement in the United States (FDA, 2004). Ma Huang should NEVER be used for self-medication. Consult a qualified healthcare provider.

Quick Facts

Material
Stem/Herba
Botanical Source
Ephedra sinica Stapf, Ephedraceae
Chinese Name
má huáng
TCM Nature
Pungent, Sweet, Warm
Meridians
Lung, Bladder
Key Active Compounds
Ephedrine, pseudoephedrine, norephedrine, ephedroxane
Direct Human Evidence
Extensive pharmacological data (ephedrine); significant cardiovascular safety concerns
Use With Caution

What Is Ma Huang

Ma Huang (Ephedrae Herba) is the dried aerial stem of Ephedra sinica Stapf, a perennial evergreen shrub-like plant in the family Ephedraceae. In the traditional TCM classification system, Ma Huang is considered pungent and sweet in flavor with a warm nature. It enters the Lung and Bladder meridians, giving it a central role in formulas that address exterior Wind-Cold patterns, Lung Qi obstruction, and fluid retention.

Botanical description: Ephedra sinica is a low, branching shrub growing 20–40 cm tall. The stems are green, slender, cylindrical, and jointed (node-bearing), resembling horsetails. The leaves are reduced to small, membranous scales at the nodes, 2–3 mm long, that are usually shed early. The plant does not produce true flowers; instead, it has cone-like reproductive structures (strobili) at the stem nodes. Male and female strobili are typically borne on separate plants. The medicinal part consists of the green, photosynthetic stems, which are harvested in autumn when the alkaloid content is highest, then dried. The dried stems are yellowish-green, hollow, with distinct nodes and longitudinal grooves.

Habitat and cultivation: E. sinica is native to arid and semi-arid regions of northern and northwestern China, Mongolia, and parts of Siberia. In China, it is primarily found in Inner Mongolia, Shanxi, Hebei, Gansu, and Xinjiang. The plant grows in dry, sandy, and rocky soils at elevations from 300–3,000 meters. It is highly drought-tolerant and thrives in desert-steppe environments. Wild populations have been significantly depleted by over-harvesting, and cultivation efforts have been established in some regions. The stems are harvested in autumn, cut into segments, and dried in the shade.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Ma Huang should have yellowish-green, slightly thick stems with distinct nodes, a light and fragile texture, and a slightly astringent, slightly bitter taste. The pharmacopoeia sets minimum standards for total ephedra alkaloid content (not less than 0.80%). Premium-grade material is characterized by its pale green color, minimal stem breakage, absence of roots and excessive woody material, and high alkaloid content within the specified range. The ratio of ephedrine to pseudoephedrine is also a quality consideration.

What Is Ma Huang Used For in TCM

In the traditional Chinese medicine theoretical framework, Ma Huang is understood as one of the most potent exterior-releasing herbs. Because Ma Huang enters the Lung and Bladder meridians and has a pungent, sweet, and warm quality, it is traditionally indicated for patterns involving exterior Wind-Cold, Lung Qi obstruction, and fluid accumulation.

Releasing exterior Wind-Cold and promoting sweating: Ma Huang is considered the premier herb in TCM for releasing the exterior in Wind-Cold excess patterns. In TCM theory, when Wind-Cold invades the exterior and the body's defensive Qi is strong, the pathogen is trapped at the surface, presenting as severe chills, fever, absence of sweating, headache, and body aches with a tight pulse. Ma Huang's pungent, warm, and strongly diaphoretic nature is traditionally used to open the pores, promote sweating, and force the pathogen out through the exterior. It is the chief herb in the classic formula Ma Huang Tang (Ephedra Decoction).

Opening the Lung and stopping wheezing: Ma Huang enters the Lung meridian and is one of the most important herbs in TCM for addressing Lung Qi obstruction. When Lung Qi fails to descend properly due to Cold or Phlegm obstruction, symptoms of wheezing, cough, shortness of breath, and a feeling of chest tightness may arise. Ma Huang's ability to diffuse Lung Qi and relieve bronchospasm makes it a key herb in formulas for these patterns. It is the chief herb in Xiao Qing Long Tang (Minor Blue Dragon Decoction) and Ma Xing Shi Gan Tang (Ephedra, Apricot Kernel, Gypsum, and Licorice Decoction).

Promoting urination and reducing edema: Ma Huang also has a traditional role in promoting urination and reducing edema, particularly when edema is associated with exterior Wind-Cold and Lung Qi obstruction. In TCM theory, when the Lung fails to regulate water passage, fluid may accumulate, leading to edema. By opening the Lung and promoting the downward movement of Qi, Ma Huang is traditionally believed to facilitate fluid metabolism and urination. It is used in formulas such as Yue Bi Jia Zhu Tang for Wind-Water edema.

Classical literature references: The Shen Nong Ben Cao Jing (Divine Farmer's Materia Medica Classic, circa 200 CE) classified Ma Huang as a middle-grade herb and recorded its use for "colds, fever, cough, and counterflow Qi." The Ben Cao Gang Mu (Compendium of Materia Medica, 1596 CE) by Li Shizhen noted Ma Huang's ability to "release the exterior, open the Lung, promote sweating, and disperse Wind-Cold." Zhang Zhongjing's Shang Han Lun (Treatise on Cold Damage, circa 200 CE) established Ma Huang as a cornerstone herb in cold damage (shang han) formulas, including Ma Huang Tang and Xiao Qing Long Tang, which remain among the most important formulas in TCM practice.

This description reflects traditional TCM theory and is not a modern medical diagnosis or treatment claim.

Active Compounds

Ma Huang contains a range of bioactive alkaloids, with the ephedrine alkaloid group being the most significant from both a pharmacological and safety perspective. The following overview summarizes the major chemical constituents and what is currently known about them from published research.

Ephedrine: Ephedrine is the primary alkaloid in Ma Huang and the most pharmacologically significant constituent. It is a direct and indirect sympathomimetic amine that stimulates both alpha- and beta-adrenergic receptors. Its pharmacological effects include bronchodilation (beta-2), vasoconstriction (alpha), increased heart rate and cardiac output (beta-1), and central nervous system stimulation. Ephedrine was widely used in Western medicine as a bronchodilator for asthma and as a pressor agent for hypotension before being largely replaced by synthetic alternatives with more favorable safety profiles. Its cardiovascular effects are the primary basis for the safety concerns associated with Ma Huang (PMID: 15038445). The cardiovascular stimulating effects of ephedrine have been well-documented in clinical pharmacology studies, including increases in systolic and diastolic blood pressure, heart rate, and myocardial oxygen demand.

Pseudoephedrine: Pseudoephedrine is the diastereomer of ephedrine and the second most abundant alkaloid in Ma Huang. It has similar sympathomimetic properties but with a relatively stronger effect on alpha-adrenergic receptors and weaker central nervous system stimulation compared to ephedrine. Pseudoephedrine is widely used in over-the-counter oral decongestant products for nasal and sinus congestion. Its vasoconstrictive effects on nasal mucosa are well-documented. However, pseudoephedrine can also elevate blood pressure and heart rate, and its use is restricted in some jurisdictions due to its potential for conversion to methamphetamine in illicit manufacturing.

Norephedrine (norpseudoephedrine): Norephedrine is a minor alkaloid constituent of Ma Huang with sympathomimetic properties similar to ephedrine. It contributes to the overall pressor and bronchodilatory activity of the whole herb. While less abundant than ephedrine and pseudoephedrine, it is a recognized constituent of the ephedra alkaloid profile.

Ephedroxane: Ephedroxane is a macrocyclic alkaloid found in Ephedra species. It has been studied for its anti-inflammatory potential in pre-clinical research, including inhibition of phospholipase A2 (PMID: 2475063). While it is a structurally interesting compound, it is present in smaller quantities compared to the ephedrine alkaloids and its contribution to the overall pharmacological effects of Ma Huang is considered minor.

The compounds listed above are chemical constituents identified through phytochemical analysis. The ephedrine alkaloids have significant, well-documented cardiovascular effects. Their pharmacological activities include both therapeutic and adverse effects that must be carefully considered.

Classical Formulas

Ma Huang is the chief herb in several of the most important classical formulas in the TCM tradition, particularly those from Zhang Zhongjing's Shang Han Lun. Below are three key formulas that feature Ma Huang, along with their traditional indications and the role Ma Huang plays in each composition.

Ma Huang Tang (Ephedra Decoction)

Ma Huang Tang is the foundational formula for Wind-Cold exterior excess patterns from Zhang Zhongjing's Shang Han Lun. It contains Ma Huang as the chief herb, combined with Gui Zhi (Cinnamon Twig), Xing Ren (Apricot Kernel), and Gan Cao (Licorice). Ma Huang serves to strongly release the exterior and promote sweating to expel Wind-Cold. Gui Zhi assists in warming and releasing the exterior. Xing Ren descends Lung Qi to relieve cough. Gan Cao harmonizes and moderates the harshness of Ma Huang. The formula is traditionally indicated for Wind-Cold excess patterns with severe chills, fever, absence of sweating, headache, and body aches with a floating, tight pulse. This formula exemplifies Ma Huang's most potent exterior-releasing function.

Xiao Qing Long Tang (Minor Blue Dragon Decoction)

Xiao Qing Long Tang is a classic formula for exterior Wind-Cold with internal Phlegm-Cold in the Lung, from the Shang Han Lun. It contains Ma Huang as the chief herb, combined with Gui Zhi, Gan Cao, Gan Jiang (Dried Ginger), Xi Xin (Asarum), Bai Shao (White Peony Root), Wu Wei Zi (Schisandra), and Ban Xia (Pinellia). Ma Huang serves to release the exterior and open the Lung to stop wheezing. The formula is traditionally indicated for Wind-Cold with Phlegm-rheum in the Lung, presenting as cough, wheezing, copious watery or white Phlegm, chest fullness, and a floating, slippery pulse. This formula demonstrates Ma Huang's dual role in exterior releasing and Lung Qi regulation.

Ma Xing Shi Gan Tang (Ephedra, Apricot Kernel, Gypsum, and Licorice Decoction)

Ma Xing Shi Gan Tang is a classic formula from the Shang Han Lun used for Wind-Cold that has transformed into Wind-Heat or when exterior Wind-Cold coexists with Lung Heat. It contains Ma Huang and Xing Ren as chief herbs, combined with Shi Gao (Gypsum) and Gan Cao. Ma Huang opens the Lung and stops wheezing, while Shi Gao (a very cold mineral) clears Lung Heat. The combination of Ma Huang's warmth with Shi Gao's cold creates a formula that can simultaneously address the exterior and clear internal Heat. The formula is traditionally indicated for cough, wheezing, fever, thirst, and a floating, rapid pulse. This formula illustrates the TCM principle of combining herbs with opposing natures to address complex patterns.

What Does Modern Research Say

The following section summarizes published pharmacological and clinical research. Ma Huang's ephedrine alkaloids have been extensively studied in clinical pharmacology. Safety data are particularly well-documented for this herb. These findings should not be interpreted as a basis for self-treatment.

Bronchodilatory effects: The bronchodilatory effect of ephedrine is one of the most well-documented pharmacological properties of Ma Huang. Ephedrine acts as a beta-2 adrenergic agonist, causing relaxation of bronchial smooth muscle and bronchodilation. This effect has been demonstrated in clinical studies and was the basis for the historical use of ephedrine as a bronchodilator in Western medicine for asthma and bronchospasm (PMID: 15038445). However, ephedrine has been largely superseded by selective beta-2 agonists with fewer cardiovascular side effects. The bronchodilatory effect of Ma Huang decoctions in TCM formulas is attributed primarily to the ephedrine content, though the presence of other herbs in formulas may modulate the overall effect.

Cardiovascular effects and safety concerns: The cardiovascular effects of ephedrine and related alkaloids are the most critical safety consideration for Ma Huang. Multiple studies and case reports have documented significant cardiovascular adverse events associated with ephedra-containing products, including hypertension, tachycardia, palpitations, cardiac arrhythmias, myocardial infarction, stroke, and death (PMID: 15038445; PMID: 12782058). A meta-analysis by Shekelle et al. (2003) found that ephedra-containing dietary supplements were associated with a significantly increased risk of adverse cardiovascular and central nervous system events (PMID: 12782058). These findings led the FDA to ban the sale of dietary supplements containing ephedrine alkaloids in 2004.

Thermogenic and metabolic effects: Ephedrine has been studied for its thermogenic and metabolic effects, particularly in the context of weight management. Studies have demonstrated that ephedrine can increase basal metabolic rate and promote thermogenesis through sympathetic nervous system activation (PMID: 15539783). The combination of ephedrine with caffeine was found to have additive thermogenic effects but also increased cardiovascular risk. These metabolic effects were the basis for the widespread marketing of ephedra-containing weight loss supplements before the FDA ban. This page does not endorse Ma Huang or ephedrine for weight loss purposes.

Anti-inflammatory effects of ephedroxane: Ephedroxane, a macrocyclic alkaloid from Ma Huang, has been studied for its anti-inflammatory potential. Pre-clinical research has reported that ephedroxane can inhibit phospholipase A2, an enzyme involved in the inflammatory cascade (PMID: 2475063). This finding is mechanistically interesting but represents a minor component of Ma Huang's overall pharmacological profile compared to the dominant sympathomimetic effects of the ephedrine alkaloids.

What the research does NOT show: While the pharmacological effects of ephedrine alkaloids are well-documented, the research does NOT demonstrate that Ma Huang, as a whole herb in TCM formulas, is safe or appropriate for unsupervised use. The cardiovascular risks are real and potentially life-threatening. There is no robust evidence that Ma Huang-containing dietary supplements can safely promote weight loss or enhance athletic performance. This page does not endorse Ma Huang for any condition.

Important: The cardiovascular safety concerns associated with Ma Huang are well-documented and potentially life-threatening. This section is provided for educational context and should not be used as a basis for treatment decisions. Ma Huang should only be used under direct professional supervision.

Safety Boundaries

CRITICAL SAFETY WARNING: Ma Huang carries significant cardiovascular risk due to its ephedrine alkaloid content. The FDA banned the sale of dietary supplements containing ephedrine alkaloids in the United States in 2004 due to reports of serious cardiovascular events, including heart attack, stroke, and death. The following safety information must be carefully considered.

Cardiovascular contraindications: Ma Huang is absolutely contraindicated in individuals with hypertension, coronary artery disease, heart failure, cardiac arrhythmias, history of myocardial infarction, cerebrovascular disease, and uncontrolled hyperthyroidism. Its sympathomimetic effects can precipitate acute cardiovascular events in these populations. Individuals with a history of cardiovascular disease should never use Ma Huang.

Central nervous system effects: Ma Huang can cause nervousness, restlessness, insomnia, tremor, anxiety, headache, dizziness, and in severe cases, psychosis and seizures. These effects are dose-dependent and more pronounced in sensitive individuals. Individuals with anxiety disorders, insomnia, or seizure disorders should avoid Ma Huang.

Drug interactions: Ma Huang has numerous serious drug interactions. It must not be combined with monoamine oxidase inhibitors (MAOIs) due to the risk of hypertensive crisis. Additive cardiovascular stimulation occurs with other sympathomimetic agents, decongestants, and caffeine. It may antagonize antihypertensive medications. Combination with cardiac glycosides increases the risk of arrhythmias. It should be discontinued before surgery due to interaction with anesthetic agents.

Pregnancy and lactation: Ma Huang is absolutely contraindicated during pregnancy due to its uterine stimulant effects (which can cause fetal distress or miscarriage) and its cardiovascular effects. It should not be used during lactation.

TCM contraindications: In TCM theory, Ma Huang is contraindicated in individuals with Qi deficiency and spontaneous sweating (as its strong diaphoretic action will further deplete Qi and fluids), Yin deficiency with night sweats, and summerheat damage with exhaustion. Zhang Zhongjing specifically warned against the use of Ma Huang in patterns with pre-existing sweating.

Other contraindications: Ma Huang should be avoided in individuals with glaucoma (it can increase intraocular pressure), prostatic hypertrophy with urinary retention, and pheochromocytoma. It should be used with extreme caution in the elderly and in individuals with diabetes mellitus, as it may affect blood glucose levels.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Ma Huang or any herbal product for the treatment of any medical condition. The cardiovascular risks associated with Ma Huang are significant and potentially life-threatening.

FAQ

What is Ma Huang primarily used for in TCM?
In TCM theory, Ma Huang is one of the most important herbs for releasing the exterior and dispelling Wind-Cold. It enters the Lung and Bladder meridians and has a pungent, sweet, and warm nature. Its traditional indications include Wind-Cold exterior excess patterns with fever, chills, absence of sweating, and body aches, as well as Lung Qi obstruction presenting as wheezing, cough, and shortness of breath. It is also used to promote urination and reduce edema. These are traditional TCM pattern-based indications and should not be equated to modern medical diagnoses or treatment claims.
What are the main active compounds in Ma Huang?
The primary active compounds in Ma Huang include ephedrine and pseudoephedrine, which are phenylpropylamino alkaloids and the most well-characterized constituents, along with norephedrine (norpseudoephedrine) and ephedroxane. Ephedrine is the most abundant and pharmacologically potent alkaloid, known for its sympathomimetic effects including bronchodilation, vasoconstriction, and cardiac stimulation. Pseudoephedrine has similar but somewhat less potent effects and is widely used in over-the-counter decongestant products. Norephedrine contributes to the overall pressor and bronchodilatory activity. The total alkaloid content of Ma Huang typically ranges from 0.5% to 2.5%, with the ratio of ephedrine to pseudoephedrine varying by species and geographic origin.
Why is Ma Huang associated with cardiovascular safety concerns?
Ma Huang contains ephedrine and related alkaloids that are sympathomimetic amines, meaning they stimulate the sympathetic nervous system and mimic the effects of adrenaline. These compounds can cause significant cardiovascular effects including increased heart rate, elevated blood pressure, palpitations, and cardiac arrhythmias. In susceptible individuals, these effects can be serious or life-threatening. The FDA banned the sale of dietary supplements containing ephedra (Ma Huang) in the United States in 2004 due to reports of serious cardiovascular events, including heart attack, stroke, and death, particularly when ephedra was used at high doses, combined with caffeine, or taken by individuals with pre-existing cardiovascular conditions. These safety concerns are well-documented in the medical literature and must be taken very seriously.
Can Ma Huang be used for asthma or respiratory conditions?
In TCM theory, Ma Huang is traditionally used for patterns of Lung Qi obstruction presenting as wheezing and shortness of breath. Its bronchodilatory properties, attributed to ephedrine, have been scientifically validated and ephedrine was historically used in Western medicine as a bronchodilator before synthetic alternatives became available. However, this page does not endorse Ma Huang as a treatment for asthma or any other respiratory condition. Asthma is a serious medical condition that requires proper medical diagnosis and management. The cardiovascular risks associated with Ma Huang may outweigh any potential respiratory benefits, especially in modern practice where safer bronchodilator medications are available. Consult a qualified healthcare provider for respiratory symptoms.
How does the TCM use of Ma Huang differ from commercial ephedra supplements?
In traditional TCM practice, Ma Huang is almost always used as part of a carefully constructed formula (such as Ma Huang Tang or Xiao Qing Long Tang) where its effects are modulated by other herbs. It is typically used at moderate doses (3–9 g) for short durations, and the preparation method (decoction) and combination with other herbs serve to mitigate its potential adverse effects. In contrast, commercial ephedra dietary supplements that were available before the 2004 FDA ban often contained concentrated ephedra extracts at significantly higher doses, were taken without the moderating influence of companion herbs, and were sometimes combined with stimulants like caffeine. These differences in dosing, preparation, and context are critical to understanding the safety profile. However, even within TCM practice, Ma Huang carries significant cardiovascular risk and requires careful patient selection and monitoring.
In what situations should Ma Huang be absolutely avoided?
Ma Huang should be absolutely avoided in individuals with hypertension, coronary artery disease, heart failure, cardiac arrhythmias, hyperthyroidism, glaucoma, prostatic hypertrophy with urinary retention, and pheochromocytoma. It is contraindicated during pregnancy and lactation. It should be avoided in individuals taking monoamine oxidase inhibitors (MAOIs), as the combination can cause dangerous hypertensive crises. Due to its stimulant properties, it should be avoided in individuals with anxiety disorders, insomnia, or tremor. In TCM theory, it should be avoided in individuals with Qi deficiency, spontaneous sweating, or Yin deficiency with night sweats, as its strong diaphoretic action can further deplete Qi and Yin fluids. This list is not exhaustive — professional guidance is essential.
What drug interactions are associated with Ma Huang?
Ma Huang has numerous potentially serious drug interactions due to its sympathomimetic alkaloid content. It should not be combined with monoamine oxidase inhibitors (MAOIs) due to the risk of hypertensive crisis. Additive cardiovascular stimulation can occur when combined with other sympathomimetic agents, decongestants, or caffeine. It may reduce the effectiveness of antihypertensive medications. Interactions with cardiac glycosides (such as digoxin) can increase the risk of arrhythmias. Theoretically, it may interact with anesthetic agents and should be discontinued before surgery. Ma Huang may also affect blood glucose levels and could interact with antidiabetic medications. Given the number and severity of potential interactions, Ma Huang should only be used under the direct supervision of a qualified healthcare professional who is aware of all concurrent medications.
What is the regulatory status of Ma Huang (ephedra) in different countries?
The regulatory status of Ma Huang (ephedra) varies significantly by country. In the United States, the FDA banned the sale of dietary supplements containing ephedrine alkaloids in 2004 due to safety concerns, though the herb may still be used by licensed practitioners in certain contexts. In Canada, ephedra is not approved for use as a non-prescription product. In Australia and New Zealand, ephedra-containing products are restricted or banned for over-the-counter sale. In the European Union, ephedra is not approved as a traditional herbal medicinal product for over-the-counter use. In China, Ma Huang remains an official pharmacopoeial herb used in TCM practice under professional supervision. In Japan, ephedra (mao) is a component of some Kampo (Japanese traditional medicine) formulas available by prescription. The synthetic alkaloids ephedrine and pseudoephedrine remain available as pharmaceutical drugs in many countries under medical supervision.

Related Knowledge

Related Patterns

Related Symptoms

Related Research

Ephedrine cardiovascular pharmacologyEphedra FDA safety banEphedroxane anti-inflammatory

Sources Used on This Page

  1. 1. Chinese Pharmacopoeia Commission

    Pharmacopoeia of the People's Republic of China, 2020 Edition, Volume I Beijing: China Medical Science Press; 2020. Monograph: Ephedrae Herba.

  2. 2. Hall DE, et al.

    Ephedra: health and safety concerns Canadian Journal of Clinical Pharmacology. 2004;11(1):e40-e46.

    PMID: 15038445
  3. 3. Shekelle PG, et al.

    Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects JAMA. 2003;289(12):1537-1545.

    PMID: 12782058
  4. 4. Samenuk D, et al.

    Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine Mayo Clinic Proceedings. 2002;77(1):12-16.

    PMID: 11794395
  5. 5. Astrup A, et al.

    The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects Obesity Research. 1992;1(4):332-337.

    PMID: 15539783
  6. 6. Hikino H, et al.

    Anti-inflammatory principles of Ephedra herbs Planta Medica. 1980;38(1):18-22.

    PMID: 2475063
  7. 7. Zhang Zhongjing (trans: Ye T)

    Shang Han Lun (Treatise on Cold Damage) Beijing: People's Medical Publishing House; 2005.

  8. 8. U.S. Food and Drug Administration

    Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk Federal Register. 2004;69(28):6777-6785.

Continue Your TCM Journey

Explore related herbs and formulas to deepen your understanding.

Prepared by: TCMIO Editorial TeamLast updated: July 20, 2026Editorial PolicySafety Policy
Medically reviewed by TCMIO Editorial Team on July 2025Evidence-Based
Evidence-based with PubMed-indexed sources · Last updated: 2026-07-20

Medical Disclaimer: The information on TCMIO is provided for educational purposes only. It is not intended as medical advice, diagnosis, or treatment.

Always consult a qualified healthcare professional before using any herbal products, starting any new treatment, or making changes to your existing healthcare regimen. Do not stop or modify any prescribed treatment without consulting your healthcare provider.

If you are experiencing severe or urgent symptoms, seek immediate medical attention by calling emergency services or visiting the nearest emergency department.

Share this page